SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-007212
Filing Date
2023-01-12
Accepted
2023-01-12 16:31:54
Documents
1
Group Members
BLACKSTONE CLARUS III L.L.C.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I/II GP L.L.C.BLACKSTONE HOLDINGS II L.P.BLACKSTONE INC.CLARUS VENTURES III GP, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d442825dsc13da.htm SC 13D/A 142812
  Complete submission text file 0001193125-23-007212.txt   144654
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Filed by) CIK: 0001597143 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1214
Type: SC 13D/A

Mailing Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065
Business Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065 (415) 529-5055
Imago BioSciences, Inc. (Subject) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92697 | Film No.: 23526231
SIC: 2834 Pharmaceutical Preparations